IL92541A0 - Doxorubicin aqueous solutions - Google Patents

Doxorubicin aqueous solutions

Info

Publication number
IL92541A0
IL92541A0 IL92541A IL9254189A IL92541A0 IL 92541 A0 IL92541 A0 IL 92541A0 IL 92541 A IL92541 A IL 92541A IL 9254189 A IL9254189 A IL 9254189A IL 92541 A0 IL92541 A0 IL 92541A0
Authority
IL
Israel
Prior art keywords
doxorubicin
aqueous solutions
physiologically acceptable
solutions
doxorubicin aqueous
Prior art date
Application number
IL92541A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL92541A0 publication Critical patent/IL92541A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Lubricants (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
IL92541A 1988-12-05 1989-12-04 Doxorubicin aqueous solutions IL92541A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27962788A 1988-12-05 1988-12-05

Publications (1)

Publication Number Publication Date
IL92541A0 true IL92541A0 (en) 1990-08-31

Family

ID=23069771

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92541A IL92541A0 (en) 1988-12-05 1989-12-04 Doxorubicin aqueous solutions

Country Status (20)

Country Link
EP (1) EP0372888B1 (hu)
JP (1) JPH02200637A (hu)
KR (1) KR920001460B1 (hu)
AT (1) ATE78402T1 (hu)
AU (1) AU612916B2 (hu)
DD (1) DD295990A5 (hu)
DE (1) DE68902223T2 (hu)
DK (1) DK609889A (hu)
ES (1) ES2044148T3 (hu)
FI (1) FI895733A0 (hu)
GR (1) GR3005391T3 (hu)
HU (1) HU204704B (hu)
IE (1) IE893867L (hu)
IL (1) IL92541A0 (hu)
NO (1) NO894811L (hu)
NZ (1) NZ231602A (hu)
OA (1) OA09898A (hu)
PT (1) PT92483B (hu)
YU (1) YU226189A (hu)
ZA (1) ZA899248B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
EP3417864A4 (en) * 2016-02-16 2019-08-21 General Incorporated Association Pharma Valley Project Supporting Organisation IMMUNOSUPPRESSION TENDERING AGENT AND USE THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.

Also Published As

Publication number Publication date
ES2044148T3 (es) 1994-01-01
DE68902223T2 (de) 1993-01-14
DD295990A5 (de) 1991-11-21
DK609889A (da) 1990-06-06
IE893867L (en) 1990-06-05
AU4591589A (en) 1990-06-07
KR900009081A (ko) 1990-07-02
NO894811L (no) 1990-06-06
EP0372888A1 (en) 1990-06-13
YU226189A (en) 1991-02-28
HUT52961A (en) 1990-09-28
FI895733A0 (fi) 1989-11-30
PT92483B (pt) 1995-08-09
DE68902223D1 (de) 1992-08-27
JPH02200637A (ja) 1990-08-08
ZA899248B (en) 1990-08-29
HU896426D0 (en) 1990-02-28
NZ231602A (en) 1991-12-23
ATE78402T1 (de) 1992-08-15
DK609889D0 (da) 1989-12-04
HU204704B (en) 1992-02-28
AU612916B2 (en) 1991-07-18
GR3005391T3 (hu) 1993-05-24
KR920001460B1 (ko) 1992-02-14
EP0372888B1 (en) 1992-07-22
OA09898A (fr) 1994-09-15
NO894811D0 (no) 1989-12-01
PT92483A (pt) 1990-06-29

Similar Documents

Publication Publication Date Title
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
IE882583L (en) Treatment of wounds
AU3356684A (en) Sterilizable storage solution for red blood cells
AU8218287A (en) Treatment of aqueous medium with copolymers containing acrylamidoalkane sulfonic acid
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
AU653371B2 (en) Pharmaceutical compositions
GR3004383T3 (hu)
ZA899248B (en) Doxorubicin aqueous solutions
DE3665320D1 (en) Stabilization of peroxidase activity in solution
NZ219284A (en) Fluoboric acid salt of n-tridecyl-2,6-dimethylmorpholine and pesticidal compositions
JPS5762218A (en) Ophthalmic solution
DE68905577T2 (de) Doxorubicin-loesungen.
ES8705866A1 (es) Procedimiento de preparar sales fungicidas
AU528128B2 (en) Sparingly water-soluble salts of pencillanic acid 1,1- dioxide
AU565723B2 (en) 1,3-bis(dimethylamino)-2-propyl-4-chlorophenoxy-acetate